Ribociclib-Letrozole Regimen Tested in Ovarian, Endometrial Cancer

Researchers examined the results of ribociclib and letrozole as a treatment for patients with  estrogen receptor-positive ovarian cancer and endometrial cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news